BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210412
DTEND;VALUE=DATE:20210413
DTSTAMP:20260409T093918
CREATED:20210210T174133Z
LAST-MODIFIED:20210210T174133Z
UID:4990-1618185600-1618271999@carb-x.org
SUMMARY:Decennial Day: 6th International Conference on Healthcare Associated Infections
DESCRIPTION:We are excited to announce ‘Decennial Day’ which will be a complimentary program to SHEA Spring 2021. Decennial Day will feature a few selected sessions from the 2020 Decennial Program to be virtually held on April 12\, 2021. More information to come on sessions and speakers at a later date. \nYou will automatically be registered for Decennial Day when you register for SHEA Spring 2021. If you wish to only sign up for Decennial Day (and not SHEA Spring) you may do so. Learn More \nCARB-X participants include Kevin Outterson\, Executive Director. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/decennial-day-6th-international-conference-on-healthcare-associated-infections/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210413
DTEND;VALUE=DATE:20210417
DTSTAMP:20260409T093918
CREATED:20210210T173700Z
LAST-MODIFIED:20210210T173700Z
UID:4988-1618272000-1618617599@carb-x.org
SUMMARY:SHEA Spring 2021 Conference
DESCRIPTION:Who should come to SHEA Spring 2021?\nSHEA members and non-members of all disciplines relating to Infection Prevention Programs\, Antibiotic Stewardship Programs\, Public Health\, Pharmacy\, Occupational Health\, Clinical Microbiology\, Quality Improvement\, and Patient Safety. If you are involved in infection prevention or infection control you need to be at SHEA Spring 2021! \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/shea-spring-2021-conference/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210423
DTSTAMP:20260409T093918
CREATED:20201202T224742Z
LAST-MODIFIED:20210216T142945Z
UID:4658-1618876800-1619135999@carb-x.org
SUMMARY:Anti-Infectives Drug Development Summit
DESCRIPTION:Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater\, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments\, biopharma\, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. \nWith some now considering the field as the new ‘Wall Street darling’\, especially given the $1 billion launch of the AMR action fund\, the Digital Anti-Infectives Drug Development Summit has arrived as the most comprehensive and industry-dedicated forum that addresses the biggest challenges in the development and commercialization of anti-infective drugs. \nBringing together 60+ senior leaders from large pharma\, innovative biotech\, academia and investment companies\, join us this April to discuss data-driven and solution-based approaches that focus on developing high value clinical candidates\, novel modalities and effective strategies\, that address market sustainability and aim for superiority. \nCARB-X participants include Kevin Outterson\, Executive Director\, who will be leading the session “Surviving FDA Approval of your Antibiotic” on Wednesday April 21 at 9:25am ET / 6:25am PDT.  He will touch upon: \n\nWhat can we learn from the past decade of FDA antibiotic approvals? •\nNiche markets where your drug can differentiate from generics\nNon-dilutive funding: CARB-X\, BARDA\, HERA\nExit: AMR Action Fund\, PASTEUR\n\nCARB-X funded companies participating include Peptilogics\, Vedanta\, Antabio\, Bioversys\, ContraFect\, Locus\, Techulon\, Summit\, and MicuRx. \nClick here to learn more.\nClick here to view the event guide.\nClick here to register.
URL:https://carb-x.org/event/anti-infectives-drug-development-summit/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210423
DTSTAMP:20260409T093918
CREATED:20201203T004458Z
LAST-MODIFIED:20210323T185340Z
UID:4692-1618876800-1619135999@carb-x.org
SUMMARY:JPIAMR Therapeutics Workshop -  Feeding the Antimicrobial Pipeline
DESCRIPTION:As AMR emerges\, new strategies for the treatment of infection and identification of resistant microbes are crucial. This JPIAMR activity\, led by the UK Medical Research Council (MRC) with support from South Africa (SAMRC)\, Korea (NRF)\, France (ANR)\, and Canada (CIHR) is delivered as part of JPIAMR’s mission to enable global coordination of research. \nThe workshop “Feeding the AMR Therapeutics Pipeline” will bring together academics\, industry\, innovators\, and policymakers to discuss the global antimicrobial development pipeline\, identify gaps and opportunities for future research and development\, and support collaboration for creative solutions to real-world problems facing therapeutics development in the context of antimicrobial resistance (AMR). \nThe workshop is organised online in three half-day sessions\, (13:00-17:00 CET) from the 20th to the 22nd of April 2021\, combining keynote presentations\, short invited talks selected from abstract submissions\, and panel discussions. \nCARB-X participants include Kevin Outterson\, Executive Director\, who will be leading session “Session 2 Choosing wisely – is your product worth developing?” which will take place between 14:50 to 15:50 CET on April 20th.    \nClick here to learn more.\nClick here to register. \n 
URL:https://carb-x.org/event/jpiamr-therapeutics-workshop-april-2021/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210423
DTSTAMP:20260409T093918
CREATED:20201221T211322Z
LAST-MODIFIED:20201221T211322Z
UID:4833-1618876800-1619135999@carb-x.org
SUMMARY:Anti-Infectives Drug Development Summit
DESCRIPTION:Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater\, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments\, biopharma\, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. \nWith some now considering the field as the new ‘Wall Street darling’\, especially given the $1 billion launch of the AMR action fund\, the Digital Anti-Infectives Drug Development Summit has arrived as the most comprehensive and industry-dedicated forum that addresses the biggest challenges in the development and commercialization of anti-infective drugs. \nBringing together 60+ senior leaders from large pharma\, innovative biotech\, academia and investment companies\, join us this April to discuss data-driven and solution-based approaches that focus on developing high value clinical candidates\, novel modalities and effective strategies\, that address market sustainability and aim for superiority. \nHere is a sneak peak of the world-class speaker faculty: \n\nCara Cassino\, Executive Vice President of R&D & Chief Medical Officer\, ContraFect\nKevin Outterson\, Executive Director\, CARB-X\nSilas Holland\, Head of External Affairs (Interim) & Director of Global Policy\, Merck & The AMR Action Fund\nDavid Powell\, Chief Scientific Officer\, Summit Therapeutics\nDave Ousterout\, Chief Scientific Officer\, Locus Biosciences\nAngela Talley\, Vice President of Clinical Development\, Spero Therapeutics\nErcem Atillasoy\, Chief Regulatory & Safety Officer\, AlloVir\nDavid Alterac\, Chief Medical Officer\, Entasis Therapeutics\n\nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/anti-infectives-drug-development-summit-2/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210423
DTEND;VALUE=DATE:20210424
DTSTAMP:20260409T093918
CREATED:20200916T175807Z
LAST-MODIFIED:20210317T173524Z
UID:4352-1619136000-1619222399@carb-x.org
SUMMARY:Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea; Public Workshop
DESCRIPTION:FDA\, NIAID and CDC are announcing a public workshop regarding the development considerations of antimicrobial drugs for the treatment of gonorrhea. The workshop will focus on the current state and nonclinical and clinical trial design considerations regarding antimicrobial drug development for gonorrhea and include the following topic areas: \n\nAnimal models\nClinical pharmacology considerations\nTrial design considerations for gonorrhea\, such as enrollment strategies\, choice of comparators and site of infection.\n\nThis meeting will be held in virtual format only. Registration is required for online attendance. \nTo learn more\, click here.\nAdditional details forthcoming.
URL:https://carb-x.org/event/development-considerations-of-antimicrobial-drugs-for-the-treatment-of-gonorrhea-public-workshop/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210424T080000
DTEND;TZID=America/Los_Angeles:20210424T123000
DTSTAMP:20260409T093918
CREATED:20210420T152404Z
LAST-MODIFIED:20210420T152404Z
UID:5306-1619251200-1619267400@carb-x.org
SUMMARY:9th Annual Cystic Fibrosis Symposium 2021
DESCRIPTION:This course is designed to increase the knowledge of managing patients with CF across the lifespan of all who interact with this population.\nAbout this Event \nThe target audience includes nurses\, respiratory therapists\, physical and occupational therapists\, social workers\, dieticians\, child life specialists\, and physicians \nClick here to learn more and register.
URL:https://carb-x.org/event/9th-annual-cystic-fibrosis-symposium-2021/
LOCATION:Auditorium at UCLA Medical Center\, Santa Monica\, 1250 16th Street\, Santa Monica\, CA\, 90404\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210427
DTEND;VALUE=DATE:20210429
DTSTAMP:20260409T093918
CREATED:20210420T152022Z
LAST-MODIFIED:20210420T152022Z
UID:5304-1619481600-1619654399@carb-x.org
SUMMARY:BactiVac Online: Virtual Network Conference 2021
DESCRIPTION:Delivering our 2021 Virtual Network Conference in an innovative online format will provide a unique opportunity to hear about the latest bacterial vaccinology research from leading international researchers in a safe environment. Talks will be delivered by a host of internationally renowned speakers from a range of disciplines\, all actively involved in the research area of bacterial vaccinology. Please view the programme for our virtual conference\, together with speaker profiles. \nThe conference is open and free to attend for BactiVac Network members only and booking is compulsory; you can apply for free membership here. Registration for the conference is now closed. \nKeep up to date by following us on @BactiVac\, using #BactiVacEvents. You can also download BactiVac Virtual Conference flyer to circulate and/or display within your organisation. \nFor any queries regarding virtual conference\, please contact us at: bactivac@contacts.bham.ac.uk \nClick here to learn more.
URL:https://carb-x.org/event/bactivac-online-virtual-network-conference-2021/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210429
DTEND;VALUE=DATE:20210501
DTSTAMP:20260409T093918
CREATED:20201207T215133Z
LAST-MODIFIED:20210127T224039Z
UID:4763-1619654400-1619827199@carb-x.org
SUMMARY:BSAC Spring Conference
DESCRIPTION:Additional details forthcoming. Click here to learn more. \n 
URL:https://carb-x.org/event/bsac-spring-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210429T110000
DTEND;TZID=America/New_York:20210429T123000
DTSTAMP:20260409T093918
CREATED:20210408T220314Z
LAST-MODIFIED:20210408T220314Z
UID:5256-1619694000-1619699400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – AMR R&D efforts in the CMC and formulation arena: Do it right the first time!
DESCRIPTION:Speaker: Aleksandar Danilovski\, Chief Scientific Officer\, Xellia Pharmaceuticals (Denmark) \nModerator: TBC \nAleksandar’s presentation will discuss: \n\nAre CMC and formulation efforts treated as the foster child in the innovation and development armament?\nUnderestimating CMC and formulation aspects can potentially cause significant delays and project failures\nAppropriate (what\, how and when) CMC and formulation innovation and development strategies can improve overall probability of project success\, can bring competitive advantages (including IP umbrella) and can reduce time to market – Do it right the first time!\n\nThe presentation will be followed by a Q&A session. \nClick here to learn more and register.
URL:https://carb-x.org/event/live-webinar-gardp-revive-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time/
LOCATION:Webinar
END:VEVENT
END:VCALENDAR